US Patent Issued on July 8 for "(17-)-3-oxoandrost-4-en-17-yl dodecanoate compositions and methods of preparation and use" (Utah Inventors)

ALEXANDRIA, Va., July 9 -- United States Patent no. 12,351,600, issued on July 8.

"(17-)-3-oxoandrost-4-en-17-yl dodecanoate compositions and methods of preparation and use" was invented by Kilyoung Kim (Salt Lake City), Mahesh V. Patel (Salt Lake City), Nachiappan Chidambaram (Salt Lake City) and Joel Frank (Salt Lake City).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed are bioavailable solid state (17-Beta)-3-Oxoandrost-4-en-17-yl dodecanoate compositions and methods of use in administration to mammals in need of thereof. The (17-Beta)-3-Oxoandrost-4-en-17-yl dodecanoate is preferably provided in a solid state crystalline form having a plurality of peaks corresponding to the peaks shown in FIG. 2,...